Position in GILD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$24,509
-$742,600 QoQ
Shares Held
194
-97.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,126
of 2,266 holders
Holding Since
Jun 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Persistent Asset Partners Ltd holds $4,144,035 across 7 Drug Manufacturers - General names. GILD ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,605 | $1,423,501 | |
| 2 | NVO |
Novo Nordisk A S
|
25,600 | $1,227,264 | |
| 3 | AZN |
Astrazeneca PLC
|
4,058 | $769,477 | |
| 4 | SNY |
Sanofi
|
14,750 | $629,235 | |
| 5 | LLY |
ELI LILLY & Co
|
56 | $67,168 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
194 | $24,509 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
50 | $2,881 |
All Filings in GILD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,509 | 194 | Shares | Sole | 2026-08-07 | |
| 2025-06-30 | $767,109 | 6,919 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||